19
Artificial Intelligence for drug discovery GTC Europe 2017 10 October 2017 Dean Plumbley Senior Machine Learning Scientist

Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Artificial Intelligence for drug discoveryGTC Europe 2017

10 October 2017

Dean Plumbley

Senior Machine Learning Scientist

Page 2: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Table of contents

1. About us

2. Hypothosis Generation

3. Current Success!

4. Drug Design using AI

5. AutoChem – Chemical Property

Prediction

6. EvoChem – Drug generation

7. Looking Ahead

Page 3: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

We are

Since our foundation in 2013, our mission has

been to bring together the best of technology

and scientific research to enable us to create

better medicines.

BenevolentAI harnesses artificial intelligence to

enhance and accelerate scientific discovery by

making sense of highly fragmented information

to create new insights and usable knowledge

that benefit society.

Page 4: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

BenevolentAI Overview

Founded in 2013

$BN company

80+ team of world class scientists and technologists (50+

doctorates/advanced degrees)

Technology enabling previously impossible tasks in bioscience

Rich patent portfolio of over 400 patents

10/10/2017 4

Page 5: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Drug Discovery is broken!

10/10/2017 5

Page 6: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

BenevolentAI is challenging traditional approaches

10/10/2017 6

Page 7: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Proprietary Knowledge and Inference Models

10/10/2017 7

Page 8: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

BenevolentAI finds potential treatments for ALS

10/10/2017 8

Page 9: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

AI driven compound design

Page 10: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Overview of AI driven compound design

10/10/2017 10

Page 11: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Drug design using AI

10/10/2017 11

MoleculeNet: A Benchmark for Molecular Machine Learning Wu et al, arXiv

2017, https://arxiv.org/abs/1703.00564

Property Prediction

Molecule Generation

Page 12: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

AutoChemDrug property prediction

Page 13: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

QSAR modelling

10/10/2017 13

Drug structures as SMILES Representation as fingerprints /

physchem descriptors

Page 14: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

QSAR modelling

10/10/2017 14

Low Data Drug Discovery with One-shot Learning Altae-Tran

et al, 2016, https://arxiv.org/abs/1611.03199

Page 15: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

AutoChem – The system

10/10/2017 15

Page 16: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

EvoChemGenerative Chemistry

Page 17: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Bespoke molecule generation

• Multiparameter optimisation of drugs is hard!

• Can AI help?

10/10/2017 17

Diversity-Oriented Synthesis: Developing New Chemical Tools to Probe and Modulate

Biological Systems Galloway et al, 2014, http://www-

spring.ch.cam.ac.uk/publications/pdf/2014_DOS_379.pdf

Page 18: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Generative models for drug design

10/10/2017 18

Automatic chemical design using a data-driven continuous representation

of molecules Gomez-Bombarelli et al, 2016,

https://arxiv.org/abs/1610.02415

Page 19: Artificial Intelligence for drug discovery · 2017-10-27 · Drug Discovery is broken! 10/10/2017 5. BenevolentAI is challenging traditional approaches 10/10/2017 6. Proprietary Knowledge

Thanks for listening!

Any Questions?

We’re hiring!

Get in touch

[email protected]